M. Sachdeva, S. Dhingra, and M. Parle, “Dapagliflozin: a new adjunct in the treatment of Type 2 diabetes mellitus”, Int J Basic Clin Pharmacol, vol. 3, no. 4, pp. 741–747, Jan. 2017.